APA (7th ed.) Citation

C, G., D, M., A, J., R, M., V, T., G, R., . . . F, R. (2018). Aberrant Splicing Is the Pathogenicity Mechanism of the p.Glu314Lys Variant in CYP11A1 Gene. Frontiers in endocrinology, 9, 491. https://doi.org/10.3389/fendo.2018.00491

Chicago Style (17th ed.) Citation

C, Goursaud, et al. "Aberrant Splicing Is the Pathogenicity Mechanism of the P.Glu314Lys Variant in CYP11A1 Gene." Frontiers in Endocrinology 9 (2018): 491. https://doi.org/10.3389/fendo.2018.00491.

MLA (9th ed.) Citation

C, Goursaud, et al. "Aberrant Splicing Is the Pathogenicity Mechanism of the P.Glu314Lys Variant in CYP11A1 Gene." Frontiers in Endocrinology, vol. 9, 2018, p. 491, https://doi.org/10.3389/fendo.2018.00491.